trending Market Intelligence /marketintelligence/en/news-insights/trending/dspk9wtzot3ix-kjmcoaoa2 content esgSubNav
In This List

Prothena chief medical officer resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Prothena chief medical officer resigns

Sarah Noonberg resigned as chief medical officer of Prothena Corp. plc.

Noonberg, who was appointed to the position in May 2017, will provide Prothena with transitional support until March 15.

Martin Koller, the company's former chief medical officer, will provide leadership for Prothena's clinical and medical organizations on a consulting basis while the company searches for a replacement.